Takeda Pharmaceutical (NYSE:TAK) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Takeda Pharmaceutical (TAK) operate in?

Takeda Pharmaceutical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

Takeda Pharmaceutical Stock (NYSE: TAK) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 1.59M
Day Range	- - -
52 Wk Range	12.58 - 16.39
Market Cap	$42.35B
P/E Ratio	45.64
Dividend Yield	4.37%
Exchange	NYSE
RSI	54
Short Interest	0.23%
Days to Cover	3.7

Recent News

Eli Lilly's $3.2B Morphic Deal Is 'Crucial,' Has 'Strategic Merit' Despite Investor Attention On Obesity: Analyst

Eli Lilly's acquisition of Morphic highlights strategic expansion in Immunology, targeting α4β7 for ulcerative colitis and Crohn's disease treatments. Goldman Sachs notes the deal's potential to strengthen Eli Lilly's pipeline, complementing existing assets.

Vandana Singh

Blackstone Nears $2.2B Deal For Sale Of Japanese Supplement Maker Alinamin: Report

Blackstone Inc. is reportedly finalizing a deal to sell Alinamin Pharmaceutical to MBK Partners for $2.17 billion. Blackstone acquired Alinamin from Takeda in 2020.

Lekha Gupta

FDA Expands Argenx's Vyvgart Label to Treat Rare Disorder

Shares of Argenx (NASDAQ: ARGX) rose nearly 4% on Friday after management announced that the FDA approved its subcutaneously administered Vyvgart Hytrulo (efgartigimod) for a second indication — chronic inflammatory demyelinating polyneuropathy (CIDP).

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Takeda Pharmaceutical Co

Sector

Health Care

Industry

Pharmaceuticals

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Takeda Pharmaceutical (TAK) stock?

You can purchase shares of Takeda Pharmaceutical (NYSE:TAK) through any online brokerage.

View our list of the best stock brokerages

Who are Takeda Pharmaceutical (TAK) competitors?

Other companies in Takeda Pharmaceutical’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

What is the target price for Takeda Pharmaceutical (TAK) stock?

There is no analysis for Takeda Pharmaceutical.

What is the forecast for Takeda Pharmaceutical (TAK) stock?

Takeda Pharmaceutical has a consensus price target of $21.33.

Current stock price for Takeda Pharmaceutical (TAK)?

The stock price for Takeda Pharmaceutical (NYSE: TAK) is $13.36 last updated July 19, 2024 at 5:07 PM EDT.

Does Takeda Pharmaceutical (TAK) pay a dividend?

There are no upcoming dividends for Takeda Pharmaceutical.

When is Takeda Pharmaceutical (NYSE:TAK) reporting earnings?

Takeda Pharmaceutical’s Q1 earnings are confirmed for Wednesday, July 31, 2024.

Is Takeda Pharmaceutical (TAK) going to split?

There is no upcoming split for Takeda Pharmaceutical.

What sector and industry does Takeda Pharmaceutical (TAK) operate in?

Takeda Pharmaceutical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Takeda Pharmaceutical

Takeda Pharmaceutical (TAK) Forecast